Pulmonary Medicine
Episodes 1-16 of 21
- Project Oncology®
Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases
Jacob Sands, MD
Aaron Lisberg, MD
- Project Oncology®
Treating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary Results
Charles Turck, PharmD, BCPS, BCCCP
Thomas Egenod, MD
Jacob Sands, MD
Aaron Lisberg, MD
- Project Oncology®
Evaluating Valemetostat and Dato-DXd for NSCLC: An Upcoming Trial
Jacob Sands, MD
Alex Spira, MD, PhD, FACP
- Project Oncology®
NSCLC Care: Predicting Response to Dato-DXd with a TROP2 Biomarker
Jacob Sands, MD
Marina Garassino, MD
- Project Oncology®
AEGEAN Trial: The Role of Perioperative Durvalumab in NSCLC
- Global Oncology Academy
Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care
Jacob Sands, MD
Aakesh Desai, MD, MPH
- Project Oncology®
Managing Immunotherapy Toxicities in Lung Cancer Patients
Jacob Sands, MD
Aliyah Pabani, MD
- Project Oncology®
Recognizing the Role of Capmatinib for METex14 in NSCLC
Jacob Sands, MD
Edward B. Garon, MD, MS
Jacob Sands, MD
Millie Das, MD
- Project Oncology®
Investigating Immunotherapy & Its Role in NSCLC
Jacob Sands, MD
Mark Awad, MD, PhD
- Project Oncology®
Evaluating Biomarkers at Work in NSCLC
Jacob Sands, MD
Mark Awad, MD, PhD
- Project Oncology®
Understanding Updates in Lung Cancer Screening
Jacob Sands, MD
Andrea B. McKee, MD
- Project Oncology®
Assessing Quality of Care: Implementing a Lung Screening Program
Jacob Sands, MD
Andrea B. McKee, MD
Jacob Sands, MD
Aaron S. Mansfield, MD
- Project Oncology®
A Step-by-Step Approach to Managing Mesothelioma
Jacob Sands, MD
Aaron S. Mansfield, MD
- Prev
- Next